Although it is still waiting for the drug’s approval, pharmaceutical company Merck has struck a deal to manufacture its COVID-19 antiviral pill Molnupiravir here in Canada. How exactly will such medications help fight the pandemic? Jamie Maraucher explains the advantage they could give patients.
- Canadian officials hopeful COVID-19 treatments will help ease strain on hospitals
- Approval of Pfizer COVID-19 pills coming in 7-10 days: Health Canada
- Newly approved COVID-19 pills come with a catch. Here’s what you should know